Projects per year
Fingerprint
- 12 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 6 Finished
-
Validation of Siglec-6 as a novel target for cancer immunotherapy
Rader, C. (PI) & Muthusamy, N. (CoPI)
08/1/18 → 07/31/20
Project: Research
-
Phosphatase activation as therapeutic strategy for Chronic lymphocyic leukemia
Muthusamy, N. (PI) & Phelps, A. M. (CoPI)
09/25/15 → 08/31/21
Project: Research
-
Novel Immunotherapies for Lymphoid Malignancies
Byrd, J. C. (PI) & Muthusamy, N. (CoPI)
07/20/12 → 04/30/15
Project: Research
-
Validation of microRNAs as therapeutic targets in hematological malignancies
Muthusamy, N. (CoPI), Chan, K.K.-H. (CoPI) & Marcucci, G. (CoPI)
03/1/11 → 02/28/17
Project: Research
-
Innate Immunity: Elucidation and Modulation for Cancer Therapy
Caligiuri, M. A. (PI), Anderson, C. L. (CoPI), Byrd, J. C. (CoPI), Carson, W. E. (CoPI), Jarjoura, D. D. G. (CoPI), Lemeshow, S. A. (CoPI), Liu, Y. (CoPI), Muthusamy, N. (CoPI) & Tridandapani, S. (CoPI)
09/30/02 → 12/31/17
Project: Research
-
CD37 in acute myeloid leukemia: a novel surface target for drug delivery
Jeremy, E., Artiga, E., Elgamal, S., Cheney, C., Eicher, D., Zalponik, K., Orwick, S., Mao, C., Wasmuth, R., Harrington, B., Mustonen, A., Beshay, P., Halley, P., Castro, C., Williams, K., Hing, Z., Chen, T., Lucas, C., Vantangoli, N. J. & Lapalombella, R. & 7 others, , Jan 14 2025, In: Blood Advances. 9, 1, p. 1-14 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A CD3 humanized mouse model unmasked unique features of T-cell responses to bispecific antibody treatment
Wang, L., Leach, V., Muthusamy, N., Byrd, J. & Long, M., Jan 23 2024, In: Blood Advances. 8, 2, p. 470-481 12 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia
Nunes, J., Tafesse, R., Mao, C., Purcell, M., Mo, X., Zhang, L., Long, M., Cyr, M. G., Rader, C. & Muthusamy, N., Dec 2024, In: Nature Communications. 15, 1, 5180.Research output: Contribution to journal › Article › peer-review
Open Access -
A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models
Chan, W. K., Williams, J., Sorathia, K., Pray, B., Abusaleh, K., Bian, Z., Sharma, A., Hout, I., Nishat, S., Hanel, W., Sloan, S. L., Yasin, A., Denlinger, N., Zhang, X., Muthusamy, N., Vasu, S., de Lima, M., Yang, Y., Baiocchi, R. & Alinari, L., Dec 2023, In: Experimental Hematology and Oncology. 12, 1, 79.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Bifunctional degraders of cyclin dependent kinase 9 (CDK9): Probing the relationship between linker length, properties, and selective protein degradation
Tokarski, R. J., Sharpe, C. M., Huntsman, A. C., Mize, B. K., Ayinde, O. R., Stahl, E. H., Lerma, J. R., Reed, A., Carmichael, B., Muthusamy, N., Byrd, J. C. & Fuchs, J. R., Jun 5 2023, In: European Journal of Medicinal Chemistry. 254, 115342.Research output: Contribution to journal › Article › peer-review
12 Scopus citations